Edoxaban
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09075 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 15 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | fibroma of prostate | KG + DL |
| 3 | benign reproductive system neoplasm | KG + DL |
| 4 | Glanzmann thrombasthenia | KG + DL |
| 5 | pseudo-von Willebrand disease | KG + DL |
| 6 | homozygous familial hypercholesterolemia | KG + DL |
| 7 | Brenner tumor | KG + DL |
| 8 | Ledderhose disease | KG + DL |
| 9 | benign prostate phyllodes tumor | KG + DL |
| 10 | prostate cancer/brain cancer susceptibility | KG + DL |
| 11 | palmar fibromatosis | KG + DL |
| 12 | infantile digital fibromatosis | KG + DL |
| 13 | male reproductive organ cancer | KG + DL |
| 14 | prostate leiomyoma | KG + DL |
| 15 | penile fibromatosis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.